ACE2 and COVID-19: The reasons for the presence of fatigue and dyspnea in post-COVID-19 patients could be because an autoimmune response to ACE2 may cause residual injury and abnormalities in the lungs that can lead to persistent fatigue and dyspnea [29,31].